Accelerated wound healing mediated by activation of Toll-like receptor 9

Wound Repair and Regeneration

Volumn 18, Issue 6, 2010, Pages 586-593

  Sato, Takashi ^a,b   Yamamoto, Masaki ^a   Shimosato, Takeshi ^a   Klinman, Dennis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASEMENT MEMBRANE EXTRACT; CELL EXTRACT; CPG OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; IN VITRO STUDY; MACROPHAGE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; WOUND HEALING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD31; BIOPSY; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGODEOXYRIBONUCLEOTIDES; SKIN; TOLL-LIKE RECEPTOR 9; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 78349239324     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2010.00632.x     Document Type: Article

References (36)

1. Singer AJ, Clark RA., Cutaneous wound healing. N Engl J Med 1999; 341: 738-46.
2. Coussens LM, Werb Z., Inflammation and cancer. Nature 2002; 420: 860-7.
3. Werner S, Grose R., Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-70.
4. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA., Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56: 549-80.
5. Frantz S, Vincent KA, Feron O, Kelly RA., Innate immunity and angiogenesis. Circ Res 2005; 96: 15-26.
6. Macedo L, Pinhal-Enfield G, Alshits V, Elson G, Cronstein BN, Leibovich SJ., Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol 2007; 171: 1774-88.
7. Krieg AM, Yi A, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM., CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374: 546-8.
8. Klinman DM, Yi A, Beaucage SL, Conover J, Krieg AM., CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFNg. Proc Natl Acad Sci USA 1996; 93: 2879-83.
9. Wagner H., Bacterial CpG-DNA activates immune cells to signal "infectious danger." Adv Immunol 1999; 73: 329-68.
10. Hemmi H, Takeuchi O, Kawai T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S., A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-5.
11. Takeshita F, Leifer CA, Gursel I, Ishii K, Takeshita S, Gursel M, Klinman DM., Cutting edge: role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001; 167: 3555-8.
12. Klinman DM., Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004; 4: 249-58.
13. Halperin SA, Van Nest G, Smith B, Abtahi S, Whiley H, Eiden JJ., A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine 2003; 21: 2461-7.
14. Rynkiewicz D, Rathkopf M, Ransom J, Sim I, Giri L, Quinn J, Waytes T, Al-Adhami M, Johnson W, Nielsen C., Marked enhancement of antibody response to anthrax vaccine adsorbed with CpG 7909 in healthy volunteers. ICAAC abstract LB-25, 2005.
15. Vollmer J, Krieg AM., Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev 2009; 61: 195-204.
16. Zheng M, Klinman DM, Gierynska M, Rouse BT., DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci USA 2002; 99: 8944-9.
17. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, Leibovich SJ., An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol 2003; 163: 711-21.
18. Fujimoto C, Klinman DM, Shi G, Yin H, Vistica BP, Lovaas JD, Wawrousek EF, Igarashi T, Chan CC, Gery I., A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin Exp Immunol 2009; 156: 528-34.
19. Tross D, Klinman DM., Effect of CpG oligonucleotides on vaccine-induced B cell memory. J Immunol 2008; 181: 5785-90.
20. Sato T, Shimosato T, Alvord WG, Klinman DM., Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation. J Immunol 2008; 180: 7648-54.
21. Devalaraja RM, Nanney LB, Du J, Qian Q, Yu Y, Devalaraja MN, Richmond A., Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol 2000; 115: 234-44.
22. Ishida Y, Gao JL, Murphy PM., Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008; 180: 569-79.
23. Sato T, Takeno M, Honma K, Yamauchi H, Saito Y, Sasaki T, Morikubo H, Nagashima Y, Takagi S, Yamanaka K, Kaneko T, Ishigatsubo Y., Heme oxygenase-1, a potential biomarker of chronic silicosis, attenuates silica-induced lung injury. Am J Respir Crit Care Med 2006; 174: 906-14.
24. Gerharz M, Baranowsky A, Siebolts U, Eming S, Nischt R, Krieg T, Wickenhauser C., Morphometric analysis of murine skin wound healing: standardization of experimental procedures and impact of an advanced multitissue array technique. Wound Repair Regen 2007; 15: 105-12.
25. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR., Basement membrane complexes with biological activity. Biochemistry 1986; 25: 312-8.
26. Pfeffer U, Bisacchi D, Morini M, Benelli R, Minghelli S, Vacca A, Noonan DM, Albini A., Human chorionic gonadotropin inhibits Kaposi's sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth. Endocrin 2002; 143: 3114-21.
27. Gorelik JV, Paramonov BA, Blinova MI, Diakonov IA, Kukhareva LV, Pinaev GP., Matrigel increases the rate of split wound healing and promotes keratinocyte utake' in deep wounds in rats. Cytotechnology 2000; 32: 79-86.
28. Klaschik S, Gursel I, Klinman DM., CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis. Mol Immunol 2007; 44: 1095-104.
29. Ishida Y, Gao JL, Murphy PM., Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008; 180: 569-79.
30. Sester DP, Brion K, Trieu A, Goodridge HS, Roberts TL, Dunn J, Hume DA, Stacey KJ, Sweet MJ., CpG DNA activates survival in murine macrophages through TLR9 and the phosphatidylinositol 3-kinase-Akt pathway. J Immunol 2006; 177: 4473-80.
31. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC., Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164: 1935-47.
32. Koff JL, Shao MX, Kim S, Ueki IF, Nadel JA., Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J Immunol 2006; 177: 8693-700.
33. Fujimoto C, Klinman DM, Yin H, Vistica BP, Wawrousek EF, Igarashi T, Chan C, Gery I., A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin Immunol Immunolpathol 2009; l156: 528-34.
34. Krieg AM., Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006; 5: 471-84.
35. Verthelyi D, Kenney RT, Seder RA, Gam AA, Friedag B, Klinman DM., CpG oligodeoxynucleotides as vaccine adjuvants in primates. J Immunol 2002; 168: 1659-63.
36. Manegold C, Gravenor D, Woytowitz D, Mezger J, Hirsh V, Albert G, Al-Adhami M, Readett D, Krieg AM, Leichman CG., Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer. J Clin Oncol 2008; 26: 3979-86.